KDM4脱甲基酶:结构,功能和抑制剂
Yuanyuan Jiang1, Lanxin Liu1, Zeng-Quan Yang2
1Department of Oncology, Karmanos Cancer Institute, Wayne State University, 4100 John R Street, HWCRC 815, Detroit, MI, 48201, USA.
Advances in experimental medicine and biology
|September 26, 2023
概括
基因表达 KDM4 基因组脱甲基酶调节基因表达,并与癌症有关. 本综述涵盖了KDM4蛋白结构,调节,病理学中的作用以及癌症治疗的潜在治疗抑制剂.
科学领域:
- 生物化学 生物化学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
背景情况:
- 基因组脱甲基酶KDM4从H3K9和H3K36中去除甲基标记,调节染色体结构和基因表达.
- 这些酶对于转录,细胞增殖,分化,DNA修复,免疫反应和干细胞更新至关重要.
- 失调的KDM4表达与各种血液和固体瘤有关,突出了它们的治疗潜力.
研究的目的:
- 总结关于KDM4蛋白质结构和调节机制的当前知识.
- 审查KDM4蛋白在人类病理过程中的变化,特别是在发育和癌症中.
- 讨论KDM4抑制剂作为潜在的治疗剂.
主要方法:
- 关于KDM4基因组脱甲基酶的文献综述.
- 对KDM4蛋白结构和调节通路的分析.
- 检查KDM4在病理条件和癌症中的参与.
主要成果:
- 在基本的生物过程中,KDM4脱甲基酶起着至关重要的作用.
- 异常的KDM4表达是许多癌症的标志.
- 已经开发出各种KDM4抑制剂,并显示出治疗的前景.
结论:
- KDM4蛋白质是关键的表观遗传调节剂,在癌症中具有重大影响.
- 了解KDM4的结构和调节对于开发有针对性的疗法至关重要.
- KDM4 抑制剂是癌症治疗的一个有前途的策略.
相关概念视频
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Phase II Reactions: Methylation Reactions
220
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
220
Dipeptidyl Peptidase 4 Inhibitors
204
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
204
Eukaryotic Transcription Inhibitors
9.9K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.9K
Spreading of Chromatin Modifications
8.3K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
8.3K


